BlackRock’s Caribou Biosciences CRBU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.37M | Sell |
1,883,476
-4,462,962
| -70% | -$5.62M | ﹤0.01% | 3948 |
|
|
2025
Q1 | $5.79M | Sell |
6,346,438
-217,751
| -3% | -$199K | ﹤0.01% | 3545 |
|
|
2024
Q4 | $10.4M | Sell |
6,564,189
-669,183
| -9% | -$1.06M | ﹤0.01% | 3359 |
|
|
2024
Q3 | $14.2M | Buy |
7,233,372
+285,552
| +4% | +$560K | ﹤0.01% | 3189 |
|
|
2024
Q2 | $11.4M | Sell |
6,947,820
-57,242
| -0.8% | -$93.9K | ﹤0.01% | 3263 |
|
|
2024
Q1 | $36M | Sell |
7,005,062
-63,406
| -0.9% | -$326K | ﹤0.01% | 2592 |
|
|
2023
Q4 | $40.5M | Buy |
7,068,468
+984,028
| +16% | +$5.64M | ﹤0.01% | 2565 |
|
|
2023
Q3 | $29.1M | Buy |
6,084,440
+1,319,831
| +28% | +$6.31M | ﹤0.01% | 2676 |
|
|
2023
Q2 | $20.2M | Buy |
4,764,609
+10,046
| +0.2% | +$42.7K | ﹤0.01% | 2971 |
|
|
2023
Q1 | $25.2M | Buy |
4,754,563
+32,480
| +0.7% | +$172K | ﹤0.01% | 2795 |
|
|
2022
Q4 | $29.7M | Buy |
4,722,083
+243,893
| +5% | +$1.53M | ﹤0.01% | 2767 |
|
|
2022
Q3 | $47.2M | Buy |
4,478,190
+428,404
| +11% | +$4.52M | ﹤0.01% | 2460 |
|
|
2022
Q2 | $22M | Buy |
4,049,786
+730,604
| +22% | +$3.97M | ﹤0.01% | 2978 |
|
|
2022
Q1 | $30.5M | Buy |
3,319,182
+1,556,153
| +88% | +$14.3M | ﹤0.01% | 2843 |
|
|
2021
Q4 | $26.6M | Buy |
1,763,029
+581,489
| +49% | +$8.77M | ﹤0.01% | 3045 |
|
|
2021
Q3 | $28.2M | Buy |
+1,181,540
| New | +$28.2M | ﹤0.01% | 3010 |
|